Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Matthew Stanton, CFA
JEF
Matthew Stanton, CFA
Wall Street Analyst
★★★☆☆
#826
on 13Foresight · ranked by our own returns
67%
Success Rate
+5.4%
Average Return
4 of 6 calls profitable · -3.6% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 67% of Matthew Stanton, CFA's ratings turned a profit when each position was held for 1 year — averaging +5.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

3 Buy 5 Hold 0 Sell
Matthew's Stock Coverage 6 ratings · 2026-06-20
Company Date Position Consensus Price Target 1-Yr Return
CYRX
CryoPort
Jun 08, 2026 HOLD Strong Buy
-4.3% avg upside
15 analysts
$13.00
11.58% Downside
·
RGEN
Repligen
May 05, 2026 HOLD Strong Buy
+28.4% avg upside
25 analysts
$142.00
7.83% Upside
-2.6%
AZTA
Azenta
Apr 01, 2026 BUY Buy
+101.3% avg upside
13 analysts
$35.00
51.25% Upside
+7.1%
MRVI
Maravai Lifesciences Holdings
Mar 18, 2025 BUY Strong Buy
+175.0% avg upside
17 analysts
$10.00
99.60% Upside
+18.2%
LAB
Standard BioTools
Apr 04, 2024 BUY Strong Buy
+645.1% avg upside
8 analysts
$3.25
290.87% Upside
-59.6%
BLFS
BioLife Solutions
Apr 04, 2024 BUY Strong Buy
+12.8% avg upside
17 analysts
$22.00
16.57% Downside
+19.2%
🔒 1 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Matthew Stanton, CFA — Frequently Asked Questions
How accurate are Matthew Stanton, CFA's stock ratings?
Based on the calls 13Foresight could measure, about 67% of Matthew's ratings were profitable over a one-year hold, with an average return of +5.4% per rating, or -3.6% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Matthew ranked on 13Foresight?
Matthew Stanton, CFA is currently ranked #826 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Matthew cover?
Matthew most recently has ratings on CYRX, RGEN, AZTA, MRVI, LAB, BLFS. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.